1 min read
Electra Therapeutics Posts $3.47 Q3 GAAP EPS as Net Loss Widens
GAAP earnings per share beat estimates by $4.44, while net loss rose from $18.1 million in the year-earlier quarter.
Electra Therapeutics, Inc. recorded a $23.9 million third-quarter net loss, compared with $18.1 million in the same period a year earlier, while GAAP earnings per share beat estimates by $4.44 and came to $3.47.